22nd Aug 2006 09:00
AstraZeneca PLC22 August 2006 AstraZeneca UK Limited Completes Acquisition of Cambridge Antibody Technology Group plc Compulsory Acquisition Procedure Completed Subsequent Offer Period Closed AstraZeneca today announced that it has completed the compulsory acquisitionprocedure under the Interim Regulations and now owns 100 percent of the issuedshare capital of CAT. The Subsequent Offer Period has now ended and the Offer is closed for furtheracceptance. Defined terms used in this announcement have the same meanings as in the OfferDocument dated 23 May 2006. 22 August 2006 Enquiries: AstraZeneca Media Enquiries:Steve Brown (London) +44 (0)20 7304 5033Edel McCaffrey (London) +44 (0) 20 7304 5034Staffan Ternby (Sweden) +46 8 553 26107 Analyst/Investor Enquiries:Jonathan Hunt (London) +44 (0) 20 7304 5087Jorgen Winroth (US) +1 212 579 0506 -Ends- This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca